Zdrowie i gospodarka · 29/06/2018
FDA Releases Draft Guidance for Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations
The FDA has published a draft guidance to help pharmaceutical companies design nonclinical studies and label their products for oncology therapeutic radiopharmaceuticals, aiming to minimize risks to patients and reduce unnecessary studies
Source: Federal Register — Food and Drug AdministrationOpen original release →